Premarket Decliner
BCTX Briacell Therapeutics Corp. - Common Shares10.92+3.28+42.9%
Premarket:4.90-6.02 (-55.1%)
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
Globe NewswireTue, 13-Jan 9:00 PM
After Hours Decliner
BCTX Briacell Therapeutics Corp. - Common Shares10.92+3.28+42.9%
After Hours:9.86-1.06 (-9.7%)
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
Globe NewswireTue, 13-Jan 9:00 PM
Premarket Decliner
BCTX Briacell Therapeutics Corp. - Common Shares6.98+0.43+6.6%
Premarket:5.53-1.45 (-20.8%)
BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+ in Prostate Cancer
Globe NewswireMon, 25-Aug 7:30 AM
After Hours Decliner
BCTX Briacell Therapeutics Corp. - Common Shares6.03+0.60+11.1%
After Hours:5.50-0.53 (-8.8%)
BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering
Globe NewswireThu, 24-Apr 8:00 PM
BCTX Briacell Therapeutics Corp. - Common Shares0.78-0.46 (-37.1%)